Browsing Tag
Japan Ministry of Health Labour and Welfare
1 post
Avidity Biosciences’ del-desiran granted orphan drug designation in Japan for myotonic dystrophy type 1
Find out how Avidity Biosciences' del-desiran could transform treatment for myotonic dystrophy type 1 after securing Japan's first Orphan Drug nod for DM1.